BNT162b2 mRNA COVID-19 Vaccine Does Not Impact the Honeymoon Phase in Type 1 Diabetes: A Case Report

Type 1 diabetes (T1D), which is caused by the autoimmune destruction of insulin-secreting pancreatic beta cells, represents a high-risk category requiring COVID-19 vaccine prioritization. Although COVID-19 vaccination can lead to transient hyperglycemia (vaccination-induced hyperglycemia; ViHG), its...

Descripción completa

Detalles Bibliográficos
Autores principales: Infante, Marco, Fabbri, Andrea, Padilla, Nathalia, Pacifici, Francesca, Di Perna, Pasquale, Vitiello, Laura, Feraco, Alessandra, Giuliano, Maria, Passeri, Marina, Caprio, Massimiliano, Ricordi, Camillo, Della-Morte, David, Uccioli, Luigi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319173/
https://www.ncbi.nlm.nih.gov/pubmed/35891261
http://dx.doi.org/10.3390/vaccines10071096

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9319173/
https://www.ncbi.nlm.nih.gov/pubmed/35891261
http://dx.doi.org/10.3390/vaccines10071096

Ejemplares similares